Answers are grounded in this paper and cite their sources.
Examines the impact of intensive chemotherapy on outcomes in TP53-mutated AML patients, suggesting significant prognostic insights.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fenwarth et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: